Epithalon vs GHRP-6
A comprehensive, data-driven comparison of Epithalon (Epitalon) and GHRP-6 (Growth Hormone Releasing Peptide-6). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Epithalon Epitalon, Epithalone | GHRP-6 Growth Hormone Releasing Peptide-6 |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Anti-Aging | Growth Hormone |
| Primary Use | Anti-aging and longevity research | Growth hormone optimization |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $40 - $80/mo | $35 - $70/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 5-10mg per cycle (10-20 days, 2-3x per year) | 100-300mcg 2-3x daily |
| Frequency | Cyclical | Daily |
| Mechanism | Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend cellular lifespan | First-generation growth hormone secretagogue that stimulates GH release and increases appetite via ghrelin mimicry |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1GHRP-6 is generally more affordable ($35 - $70/mo) compared to Epithalon ($40 - $80/mo).
- 2Epithalon is dosed cyclical, while GHRP-6 is daily.
- 3They belong to different categories: Epithalon (Anti-Aging) vs GHRP-6 (Growth Hormone).
Which Is Better For...
GHRP-6
More budget-friendly option with lower monthly costs
Epithalon
More convenient dosing schedule (cyclical)
Epithalon
Fewer commonly reported side effects
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Epithalon | $40 - $80/mo | Not submitted | Various research labs |
| GHRP-6 | $35 - $70/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Epithalon works via Tetrapeptide that may activate telomerase enzyme to lengthen telomeres and potentially extend. GHRP-6 works via First-generation growth hormone secretagogue that stimulates GH release and increases appetite via. They differ in FDA approval status, efficacy data, and cost.
Epithalon typically costs $40 - $80/mo, while GHRP-6 costs $35 - $70/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Epithalon is not FDA-approved (Not submitted). GHRP-6 is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Epithalon include Injection site reactions, Mild drowsiness, Vivid dreams. Common side effects of GHRP-6 include Significant increase in appetite, Water retention, Tingling or numbness. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched primarily in Russia for its potential anti-aging properties. The proposed mechanism involves activation of telomerase, an enzyme that...
View Full Epithalon GuideGHRP-6 is a synthetic hexapeptide and one of the first growth hormone releasing peptides developed. It stimulates GH secretion by activating the ghrelin receptor. Unlike later-generation peptides like...
View Full GHRP-6 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Epithalon and GHRP-6 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.